- Home
- TRVI vs VVR Comparison
TRVI vs VVR Comparison
Compare TRVI & VVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- VVR
- Stock Information
- Founded
- TRVI 2011
- VVR 1998
- Country
- TRVI United States
- VVR United States
- Employees
- TRVI N/A
- VVR N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- VVR Trusts Except Educational Religious and Charitable
- Sector
- TRVI Health Care
- VVR Finance
- Exchange
- TRVI Nasdaq
- VVR Nasdaq
- Market Cap
- TRVI 629.8M
- VVR 544.1M
- IPO Year
- TRVI 2019
- VVR N/A
- Fundamental
- Price
- TRVI $5.96
- VVR $3.61
- Analyst Decision
- TRVI Strong Buy
- VVR
- Analyst Count
- TRVI 8
- VVR 0
- Target Price
- TRVI $19.31
- VVR N/A
- AVG Volume (30 Days)
- TRVI 2.5M
- VVR 692.2K
- Earning Date
- TRVI 08-07-2025
- VVR 01-01-0001
- Dividend Yield
- TRVI N/A
- VVR 11.38%
- EPS Growth
- TRVI N/A
- VVR N/A
- EPS
- TRVI N/A
- VVR N/A
- Revenue
- TRVI N/A
- VVR N/A
- Revenue This Year
- TRVI N/A
- VVR N/A
- Revenue Next Year
- TRVI N/A
- VVR N/A
- P/E Ratio
- TRVI N/A
- VVR N/A
- Revenue Growth
- TRVI N/A
- VVR N/A
- 52 Week Low
- TRVI $2.36
- VVR $3.55
- 52 Week High
- TRVI $7.48
- VVR $4.38
- Technical
- Relative Strength Index (RSI)
- TRVI 43.31
- VVR 41.86
- Support Level
- TRVI $6.05
- VVR $3.70
- Resistance Level
- TRVI $6.49
- VVR $3.78
- Average True Range (ATR)
- TRVI 0.53
- VVR 0.07
- MACD
- TRVI -0.05
- VVR -0.01
- Stochastic Oscillator
- TRVI 27.62
- VVR 14.29
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About VVR Invesco Senior Income Trust (DE)
Invesco Senior Income Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide a high level of current income, consistent with the preservation of capital. The company invests in a portfolio of interests in floating or variable senior loans to corporations, partnerships, and other entities which operate in a variety of industries and geographic regions.